Published in Ann Intern Med on October 01, 2002
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61
Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res (2006) 2.61
Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int (2009) 2.15
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. J Am Soc Nephrol (2007) 1.92
Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ (2009) 1.84
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis (2008) 1.82
Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol (2003) 1.72
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71
A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.57
Renal impairment predicts long-term mortality risk after acute myocardial infarction. J Am Soc Nephrol (2007) 1.57
Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart (2003) 1.55
Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol (2004) 1.26
Online clinical pathway for managing adults with chronic kidney disease. Can Pharm J (Ott) (2015) 1.25
Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. Br J Gen Pract (2008) 1.23
Cystatin C--a paradigm of evidence based laboratory medicine. Clin Biochem Rev (2008) 1.17
Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol (2008) 1.12
Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option? J Am Soc Nephrol (2013) 1.07
HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study. BMC Nephrol (2003) 1.05
Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol (2008) 1.01
Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase. EBioMedicine (2016) 0.91
Decreased Glomerular Filtration Rate is an Independent Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J (2011) 0.90
Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Can J Cardiol (2006) 0.89
Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant (2010) 0.88
Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium. Vasc Health Risk Manag (2011) 0.88
Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction. PLoS One (2012) 0.88
Increased cardiovascular risk associated with reduced kidney function. Am J Nephrol (2009) 0.87
Dynamic TIMI risk score for STEMI. J Am Heart Assoc (2013) 0.87
The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study. BMC Cardiovasc Disord (2009) 0.86
Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart (2003) 0.86
Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Int Suppl (2011) (2013) 0.86
Establishing a national knowledge translation and generation network in kidney disease: the CAnadian KidNey KNowledge TraNslation and GEneration NeTwork. Can J Kidney Health Dis (2014) 0.85
Renal function at hospital admission and mortality due to acute kidney injury after myocardial infarction. PLoS One (2012) 0.85
Cardiovascular morbidity and mortality and renal artery stenosis. Prog Cardiovasc Dis (2009) 0.84
Renal dysfunction in heart failure patients: what is the evidence? Heart Fail Rev (2007) 0.83
Comorbid Heart Failure and Renal Impairment: Epidemiology and Management. Cardiorenal Med (2012) 0.83
Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) (2013) 0.82
Impact of acute kidney injury on clinical outcomes after ST elevation acute myocardial infarction. Yonsei Med J (2011) 0.81
Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes. Am J Kidney Dis (2008) 0.81
Chronic kidney disease in acute coronary syndromes. World J Nephrol (2012) 0.81
Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome. BMC Nephrol (2013) 0.80
Combined effects of admission serum creatinine concentration with age and gender on the prognostic significance of subjects with acute ST-elevation myocardial infarction in China. PLoS One (2014) 0.79
Decade-long trends (1999-2009) in the characteristics, management, and hospital outcomes of patients hospitalized with acute myocardial infarction with prior diabetes and chronic kidney disease. Int J Nephrol Renovasc Dis (2015) 0.79
Kidney function and estimated vascular risk in patients with primary dyslipidemia. Open Cardiovasc Med J (2009) 0.79
Therapeutic management in patients with renal failure who experience an acute coronary syndrome. Clin J Am Soc Nephrol (2009) 0.79
Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol (2009) 0.79
Impact of renal dysfunction on clinical outcomes of acute coronary syndrome. Yonsei Med J (2009) 0.79
Association of decreased glomerular filtration rate with racial differences in survival after acute myocardial infarction. Clin J Am Soc Nephrol (2011) 0.78
Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort. BMJ Open (2015) 0.78
Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies. BMC Cardiovasc Disord (2009) 0.78
Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up. PLoS One (2016) 0.78
Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention. J Zhejiang Univ Sci B (2012) 0.77
Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Curr Hypertens Rep (2015) 0.77
Mode of Coronary Revascularization and Short term Clinical Outcomes in Patients with Chronic Kidney Disease. Pak J Med Sci (2015) 0.77
Use of secondary prevention medications among adults with reduced kidney function. Clin J Am Soc Nephrol (2012) 0.77
Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study. BMC Cardiovasc Disord (2015) 0.77
Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 years. BMC Cardiovasc Disord (2011) 0.76
Chronic kidney disease: Absence of evidence or evidence of absence? ACS treatment in CKD. Nat Rev Nephrol (2010) 0.75
Plasma alkaline phosphatase and survival in diabetic patients with acute myocardial infarction. Ann Transl Med (2016) 0.75
Chronic kidney disease and cardiovascular therapeutics: time to close the evidence gaps. J Am Coll Cardiol (2011) 0.75
Cardiac mortality in chronic kidney disease: a clearer perspective. Ann Intern Med (2002) 0.75
High serum C-reactive protein level predicts mortality in patients with stage 3 chronic kidney disease or higher and diabetic foot infections. Kidney Res Clin Pract (2013) 0.75
Renal insufficiency. The prognostic value of renal function in patients with congestive heart failure and acute myocardial infarction. Rev Cardiovasc Med (2003) 0.75
Summaries for patients. Kidney disease and heart attacks. Ann Intern Med (2002) 0.75
Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting. J Nephrol (2006) 0.75
The effect of admission creatinine levels on one-year mortality in acute myocardial infarction. ScientificWorldJournal (2012) 0.75
Influence of Renal Insufficiency on the Prescription of Evidence-Based Medicines in Patients With Coronary Artery Disease and Its Prognostic Significance: A Retrospective Cohort Study. Medicine (Baltimore) (2016) 0.75
The impact of moderate to severe renal insufficiency on patients with acute myocardial infarction. Korean Circ J (2011) 0.75
The effect of experimental streptococcus infection in myocarditis on some biochemical and inflammatory markers in albino rats. Afr Health Sci (2013) 0.75
Renocardiac syndromes: physiopathology and treatment stratagems. Can J Kidney Health Dis (2015) 0.75
Connecting the C's: coronaries, creatinine, compliance, CRUSADE. Am J Kidney Dis (2009) 0.75
Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment. Am J Cardiol (2012) 0.75
Coronary Artery Bypass Surgery in End-Stage Renal Disease Patients. Ann Vasc Dis (2017) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med (2008) 14.40
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA (2002) 7.20
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol (2006) 6.66
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int (2004) 6.04
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med (2011) 5.11
Non-evidence-based ICD implantations in the United States. JAMA (2011) 5.05
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int (2009) 4.72
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64
Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA (2009) 4.29
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol (2005) 3.96
Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol (2008) 3.93
Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol (2002) 3.83
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2013) 3.83
Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med (2007) 3.80
Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med (2004) 3.64
Fostering accountable health care: moving forward in medicare. Health Aff (Millwood) (2009) 3.52
Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med (2010) 3.45
A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37
Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol (2009) 3.28
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol (2004) 3.22
A prescription for a modern Medicare program. N Engl J Med (2005) 3.21
Population ageing and wellbeing: lessons from Japan's long-term care insurance policy. Lancet (2011) 3.15
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant (2010) 3.10
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol (2013) 3.03
Nephrology consultation in acute renal failure: does timing matter? Am J Med (2002) 2.95
Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92
Cost containment and quality of care in Japan: is there a trade-off? Lancet (2011) 2.87
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res (2004) 2.83
Acute renal failure definitions and classification: time for change? J Am Soc Nephrol (2003) 2.81
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell (2009) 2.79
Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J (2007) 2.76
Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol (2002) 2.74
Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry (2005) 2.73
Building the path to accountable care. N Engl J Med (2011) 2.70
Significance of frailty among dialysis patients. J Am Soc Nephrol (2007) 2.62
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61
An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health (2009) 2.60
Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2006) 2.56
Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 2.55
Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54
Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int (2004) 2.52
Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care (2010) 2.51
Cognitive impairment in chronic kidney disease. J Am Geriatr Soc (2004) 2.50
Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation (2010) 2.45
A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone. Ann Intern Med (2005) 2.40
Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med (2009) 2.39
The case against calcium-based phosphate binders. Clin J Am Soc Nephrol (2006) 2.38
Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr (2004) 2.37
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging (2013) 2.35
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol (2008) 2.32
Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30
Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol (2006) 2.26
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23
Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr (2003) 2.19
National trends in outcomes among elderly patients with heart failure. Am J Med (2006) 2.13
Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10
Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med (2012) 2.10
Statins and cognitive function: a systematic review. Ann Intern Med (2013) 2.10
Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc (2006) 2.04
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation (2012) 2.03
Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol (2011) 2.02
Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med (2010) 2.00
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J (2011) 2.00
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail (2011) 1.99
Acute kidney injury and mortality in hospitalized patients. Am J Nephrol (2012) 1.99
Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol (2005) 1.98
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int (2005) 1.96
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int (2002) 1.96
Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm (2011) 1.93
Control of hypertension in adults with chronic kidney disease in the United States. Hypertension (2005) 1.92
Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant (2011) 1.92
Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol (2008) 1.92
Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis (2005) 1.91
Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol (2006) 1.91
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J (2004) 1.90
Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation (2003) 1.89